ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
How to manage overactive bladder
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 147656" data-attributes="member: 13851"><p><strong><span style="color: rgb(184, 49, 47)">ABSTRACT</span></strong></p><p></p><p><em>Overactive bladder (OAB) is a common and distressing condition that is known to increase with age and has a significant effect on the quality of life. Whilst OAB is a symptomatic diagnosis, many patients will require basic investigations prior to initiating the appropriate management. This article will review the initial clinical assessment and management of women complaining of OAB including conservative measures and drug therapy, and will also focus on the role of estrogen. In addition, the management of refractory OAB will also be discussed including more invasive strategies such as neuromodulation, Botulinum Toxin, and reconstructive surgery.</em></p><p></p><p></p><p></p><p></p><p><strong>Conclusions</strong></p><p></p><p><em><strong>Overactive bladder is a common and distressing condition that is known to have a significant effect on HRQoL. The clinical diagnosis of OAB is often one of exclusion, although urodynamic investigations are helpful in those women with refractory or unusual symptoms. The majority of women will benefit from conservative measures in the first instance although many will eventually require drug therapy. For those with refractory symptoms, switching to an alternative class of therapy may be useful and there is now considerable evidence to support the use of combination therapy in those women with persistent symptoms. <u>The available evidence would also appear to suggest that, whilst systemic estrogen does not have a role in treating OAB, vaginal estrogen may be helpful and may also act synergistically with antimuscarinic drugs</u>. Those patients with refractory OAB who fail to improve with medical therapy may benefit from intravesical Botulinum Toxin or neuromodulation.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 147656, member: 13851"] [B][COLOR=rgb(184, 49, 47)]ABSTRACT[/COLOR][/B] [I]Overactive bladder (OAB) is a common and distressing condition that is known to increase with age and has a significant effect on the quality of life. Whilst OAB is a symptomatic diagnosis, many patients will require basic investigations prior to initiating the appropriate management. This article will review the initial clinical assessment and management of women complaining of OAB including conservative measures and drug therapy, and will also focus on the role of estrogen. In addition, the management of refractory OAB will also be discussed including more invasive strategies such as neuromodulation, Botulinum Toxin, and reconstructive surgery.[/I] [B]Conclusions[/B] [I][B]Overactive bladder is a common and distressing condition that is known to have a significant effect on HRQoL. The clinical diagnosis of OAB is often one of exclusion, although urodynamic investigations are helpful in those women with refractory or unusual symptoms. The majority of women will benefit from conservative measures in the first instance although many will eventually require drug therapy. For those with refractory symptoms, switching to an alternative class of therapy may be useful and there is now considerable evidence to support the use of combination therapy in those women with persistent symptoms. [U]The available evidence would also appear to suggest that, whilst systemic estrogen does not have a role in treating OAB, vaginal estrogen may be helpful and may also act synergistically with antimuscarinic drugs[/U]. Those patients with refractory OAB who fail to improve with medical therapy may benefit from intravesical Botulinum Toxin or neuromodulation.[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
How to manage overactive bladder
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top